{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:00:04Z","timestamp":1791907204848,"version":"4.3.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n To determine the distribution of microorganisms isolated from tracheal aspirate (TA) cultures and their antimicrobial susceptibility patterns, and to assess resistance differences between intensive care unit (ICU) \u2013 and ward-derived isolates as well as temporal trends across years.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Tracheal aspirate specimens obtained at a tertiary-care center between 2018 and 2022 were retrospectively reviewed. Only growth meeting laboratory acceptance criteria for causative pathogens was analyzed (semi-quantitative culture thresholds with cytologic quality control). Bacterial identification was performed using automated systems, and antimicrobial susceptibility testing was interpreted according to EUCAST standards. In addition to descriptive analyses, annual resistance trends and a joinpoint regression analysis (annual percent change) were conducted.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Of all causative isolates, 83.8% were Gram-negative. The most frequent pathogens were\n Klebsiella<\/jats:italic>\n spp.,\n Acinetobacter<\/jats:italic>\n spp., and\n Pseudomonas<\/jats:italic>\n spp. For\n Klebsiella<\/jats:italic>\n spp., resistance to cephalosporins and fluoroquinolones was generally &gt;90%, meropenem &gt;80%, whereas imipenem showed comparatively higher susceptibility. In\n Acinetobacter<\/jats:italic>\n spp., resistance was very high to most agents, with amikacin showing the lowest resistance. In\n Pseudomonas<\/jats:italic>\n spp., resistance rates ranged from 40% to 55%, and amikacin emerged as the most active agent. Resistance was systematically higher in ICU-derived isolates than in ward isolates. Joinpoint analysis identified a single breakpoint around 2020; resistance trajectories during 2018\u20132020 were heterogeneous, with increases observed for some organism\u2013antimicrobial combinations, followed by divergent patterns thereafter.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n The predominance of Gram-negative pathogens and the high resistance burden in our center support locally tailored Gram-negative coverage for empiric therapy alongside early de-escalation. Temporal patterns underscore the need to update empiric policies using annual local surveillance data and to reinforce infection control and antimicrobial stewardship, particularly in ICUs.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2026.1770208","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:47:24Z","timestamp":1770706044000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of microorganisms isolated from tracheal aspirate cultures and their antibiotic susceptibility profiles: a retrospective study from 2018 to 2022"],"prefix":"10.3389","volume":"13","author":[{"given":"Erkan","family":"Sanmak","sequence":"first","affiliation":[{"name":"Ministry of Health, Head of the Department of Health Professions","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130smail","family":"Davarci","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Trakya University","place":["Edirne, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl \u015eahika","family":"G\u00f6kdemir","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Mardin Artuklu University","place":["Mardin, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"G\u00fcler","sequence":"additional","affiliation":[{"name":"Ministry of Health, General Directorate of Health Services","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayri","family":"Canbaz","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Yenimahalle Training and Research Hospital, Y\u0131ld\u0131r\u0131m Beyaz\u0131t University","place":["Ankara, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Ayaydin","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Faculty of Medicine, Mardin Artuklu University","place":["Mardin, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kabak","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Faculty of Medicine, Mardin Artuklu University","place":["Mardin, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bar\u0131\u015f","family":"\u00c7il","sequence":"additional","affiliation":[{"name":"Department of Chest Diseases, Mardin Training and Research Hospital","place":["Mardin, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41479-022-00096-z","article-title":"Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns.","volume":"14","author":"Assefa","year":"2022","journal-title":"Pneumonia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(25)00689-9","article-title":"Global burden of lower respiratory infections and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.","volume":"25","author":"Sirota","year":"2025","journal-title":"Lancet Infect Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"7268519","DOI":"10.1155\/2020\/7268519","article-title":"Risk factors of multidrug-resistant bacteria in lower respiratory tract infections: a systematic review and meta-analysis.","volume":"2020","author":"Chen","year":"2020","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/jac\/dky279","article-title":"Frequency and antimicrobial susceptibility of gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015\u20132017).","volume":"73","author":"Sader","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"B5","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00134-019-05890-w","article-title":"Ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria: understanding nebulization of aminoglycosides and colistin.","volume":"46","author":"Rouby","year":"2020","journal-title":"Intensive Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2019.00262","article-title":"Molecular epidemiology and risk factors of ventilator-associated pneumonia infection caused by carbapenem-resistant Enterobacteriaceae.","volume":"10","author":"Gao","year":"2019","journal-title":"Front Pharmacol"},{"key":"B7","unstructured":"Antimicrobial Susceptibility Testing Standardization of the Turkish Society of Microbiology.\n \n 2025"},{"key":"B8","unstructured":"EUCAST: Clinical Breakpoints and Dosing Recommendations.\n \n 2025"},{"key":"B9","unstructured":"Regulation on the Procedures and Principles of Intensive Care Services in Inpatient Health Facilities.\n \n 2011"},{"key":"B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-22062-8_1","article-title":"Introduction to pneumonia.","volume-title":"Clinical Management of Bacterial Pneumonia.","author":"Torres","year":"2015"},{"key":"B11","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13756-016-0150-3","article-title":"Prevention of hospital-acquired pneumonia in non-ventilated adult patients: a narrative review.","volume":"5","author":"P\u00e1ssaro","year":"2016","journal-title":"Antimicrob Resist Infect Control"},{"key":"B12","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/jcm9010275","article-title":"Epidemiology, treatment, and prevention of nosocomial bacterial pneumonia.","volume":"9","author":"Jean","year":"2020","journal-title":"J Clin Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1186\/s13104-017-3000-3","article-title":"Molecular etiological profile of atypical bacterial pathogens, viruses, and coinfections among infants and children with community-acquired pneumonia admitted to a national hospital in Lima, Peru.","volume":"10","author":"Del Valle-Mendoza","year":"2017","journal-title":"BMC Res Notes."},{"key":"B14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jgar.2016.12.016","article-title":"Epidemiology of multidrug-resistant gram-negative pathogens isolated from ventilator-associated pneumonia in ICU patients.","volume":"9","author":"Gupta","year":"2017","journal-title":"J Glob Antimicrob Resist"},{"key":"B15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21608\/zjps.2017.38127","article-title":"Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from ventilator-associated pneumonia patients.","volume":"26","author":"Yehia","year":"2017","journal-title":"Zagazig J Pharm Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3329\/bccj.v4i2.30019","article-title":"Antibiotic resistance pattern among bacteria causing ventilator-associated pneumonia in an intensive care unit of Bangladesh.","volume":"4","author":"Ahsan","year":"2016","journal-title":"Bangladesh Crit Care J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/CCM.0000000000003553","article-title":"A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia.","volume":"47","author":"Ibn Saied","year":"2019","journal-title":"Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/QCO.0000000000000596","article-title":"An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant gram-negative bacteria.","volume":"32","author":"Cill\u00f3niz","year":"2019","journal-title":"Curr Opin Infect Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijantimicag.2014.01.007","article-title":"Antimicrobial susceptibility of gram-negative organisms isolated from patients hospitalised with pneumonia in US and European hospitals: results from the SENTRY antimicrobial surveillance program, 2009\u20132012.","volume":"43","author":"Sader","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"B20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jgar.2019.01.028","article-title":"Bacteriologic profile and susceptibility pattern of mechanically ventilated paediatric patients with pneumonia.","volume":"18","author":"El-Nawawy","year":"2019","journal-title":"J Glob Antimicrob Resist"},{"key":"B21","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1186\/s12890-021-01773-3","article-title":"Identification and detection of pathogenic bacteria from patients with hospital-acquired pneumonia in southwestern Iran: evaluation of biofilm production and molecular typing of bacterial isolates.","volume":"21","author":"Mazloomirad","year":"2021","journal-title":"BMC Pulm Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/MCC.0000000000000534","article-title":"Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug-resistant, extensively drug-resistant, and pandrug-resistant bacteria.","volume":"24","author":"Bassetti","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"B23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/diagnostics9020037","article-title":"The basics and advancements in diagnosis of bacterial lower respiratory tract infections.","volume":"9","author":"Noviello","year":"2019","journal-title":"Diagnostics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e145","DOI":"10.1542\/neo.20-3-e145","article-title":"Challenging the \u201cculture\u201d of the tracheal aspirate.","volume":"20","author":"Claassen","year":"2019","journal-title":"NeoReviews"},{"key":"B25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1513\/AnnalsATS.201506-368BC","article-title":"Use of tracheal aspirate culture in newly intubated patients with community-onset pneumonia.","volume":"13","author":"McCauley","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1128\/JCM.01494-14","article-title":"Endotracheal aspirate and bronchoalveolar lavage fluid analysis: interchangeable diagnostic modalities in suspected ventilator-associated pneumonia?","volume":"52","author":"Scholte","year":"2014","journal-title":"J Clin Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3346\/jkms.2011.26.7.865","article-title":"Usefulness of quantitative endotracheal aspirate cultures in intensive care unit patients with suspected pneumonia.","volume":"26","author":"Shin","year":"2011","journal-title":"J Korean Med Sci"},{"key":"B28","volume-title":"WHO Model Prescribing Information: Drugs used in Bacterial Infections.","year":"2001"},{"key":"B29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-981-15-4506-1_21","article-title":"Emerging the notion and definition of NHCAP: what is NHCAP? Why aspiration pneumonia is important in NHCAP?","volume-title":"Aspiration Pneumonia: the Current Clinical Giant for Respiratory Physicians.","author":"Seki","year":"2020"},{"key":"B30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.resinv.2015.01.003","article-title":"Update on the pathogenesis and management of pneumonia in the elderly: roles of aspiration pneumonia.","volume":"53","author":"Teramoto","year":"2015","journal-title":"Respir Investig"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/cid\/ciy631","article-title":"A therapeutic strategy for all pneumonia patients: a 3-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.","volume":"68","author":"Maruyama","year":"2019","journal-title":"Clin Infect Dis"},{"key":"B32","doi-asserted-by":"publisher","first-page":"16517","DOI":"10.12688\/f1000research.16517.2","article-title":"Current trends in the treatment of pneumonia due to multidrug-resistant gram-negative bacteria.","volume":"8","author":"Watkins","year":"2019","journal-title":"F1000Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1089\/sur.2016.255","article-title":"Specific clinical profile and risk factors for mortality in general surgery patients with infections by multidrug-resistant gram-negative bacteria.","volume":"18","author":"Rubio-Perez","year":"2017","journal-title":"Surg Infect"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3390\/molecules25061340","article-title":"Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it.","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"B35","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.idc.2017.07.015","article-title":"Bacterial pneumonia in older adults.","volume":"31","author":"Henig","year":"2017","journal-title":"Infect Dis Clin North Am"},{"key":"B36","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14303\/jrest.2018.020","article-title":"Review on hospital wastewater as a source of emerging drug resistance pathogens.","volume":"7","author":"Asfaw","year":"2018","journal-title":"J Res Environ Sci Toxicol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1089\/mdr.2015.0220","article-title":"Multidrug-resistant gram-negative bacterial infections in the hospital setting: overview, implications for clinical practice, and emerging treatment options.","volume":"22","author":"Cerceo","year":"2016","journal-title":"Microb Drug Resist"},{"key":"B38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fmed.2019.00105","article-title":"Antimicrobial resistance in Nepal.","volume":"6","author":"Acharya","year":"2019","journal-title":"Front Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1770208\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:47:27Z","timestamp":1770706047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1770208\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":38,"alternative-id":["10.3389\/fmed.2026.1770208"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1770208","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"1770208"}}